EP0119259A4 - Virus de l'hepatite non a, non b, procedes d'identification, de purification, de caracterisation, de diagnostic et d'immunisation. - Google Patents

Virus de l'hepatite non a, non b, procedes d'identification, de purification, de caracterisation, de diagnostic et d'immunisation.

Info

Publication number
EP0119259A4
EP0119259A4 EP19830903249 EP83903249A EP0119259A4 EP 0119259 A4 EP0119259 A4 EP 0119259A4 EP 19830903249 EP19830903249 EP 19830903249 EP 83903249 A EP83903249 A EP 83903249A EP 0119259 A4 EP0119259 A4 EP 0119259A4
Authority
EP
European Patent Office
Prior art keywords
immunization
characterization
diagnosis
purification
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19830903249
Other languages
German (de)
English (en)
Other versions
EP0119259A1 (fr
Inventor
Jack Wands
David A Shafritz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of EP0119259A1 publication Critical patent/EP0119259A1/fr
Publication of EP0119259A4 publication Critical patent/EP0119259A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19830903249 1982-09-16 1983-09-16 Virus de l'hepatite non a, non b, procedes d'identification, de purification, de caracterisation, de diagnostic et d'immunisation. Withdrawn EP0119259A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41870882A 1982-09-16 1982-09-16
US418708 1982-09-16

Publications (2)

Publication Number Publication Date
EP0119259A1 EP0119259A1 (fr) 1984-09-26
EP0119259A4 true EP0119259A4 (fr) 1988-08-04

Family

ID=23659257

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19830903249 Withdrawn EP0119259A4 (fr) 1982-09-16 1983-09-16 Virus de l'hepatite non a, non b, procedes d'identification, de purification, de caracterisation, de diagnostic et d'immunisation.

Country Status (3)

Country Link
EP (1) EP0119259A4 (fr)
JP (1) JPS59501774A (fr)
WO (1) WO1984001107A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
FR2615863B1 (fr) * 1987-05-26 1989-11-10 Inst Nat Sante Rech Med Virus apparente au virus de l'hepatite virale b, ses divers constituants et leur application au diagnostic d'une hepatite virale et a la vaccination contre cette maladie
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002598A1 (fr) * 1979-05-21 1980-11-27 Us Commerce Procede de detection de l'antigene associe de l'hepatite non-a, non-b
EP0027657A2 (fr) * 1979-10-22 1981-04-29 The Massachusetts General Hospital Procédé de préparation d'anticorps du virus de l'hépatite et lignées cellulaires pour cette préparation
US4291020A (en) * 1980-05-16 1981-09-22 The United States Of America As Represented By The Secretary Of Health & Human Services Inactivation of non-A, non-B hepatitis agent
WO1982002661A1 (fr) * 1981-01-30 1982-08-19 Inc Centocor Essai immunologique pour antigenes multi-determinants
WO1982003330A1 (fr) * 1981-03-30 1982-10-14 Christian Trepo Procede de preparation d'antigenes de l'hepatite virale nanb, et application a la realisation d'un reactif permettant le diagnostic et le pronostic des infections provoquees par les virus des hepatites virales

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002598A1 (fr) * 1979-05-21 1980-11-27 Us Commerce Procede de detection de l'antigene associe de l'hepatite non-a, non-b
EP0027657A2 (fr) * 1979-10-22 1981-04-29 The Massachusetts General Hospital Procédé de préparation d'anticorps du virus de l'hépatite et lignées cellulaires pour cette préparation
US4291020A (en) * 1980-05-16 1981-09-22 The United States Of America As Represented By The Secretary Of Health & Human Services Inactivation of non-A, non-B hepatitis agent
WO1982002661A1 (fr) * 1981-01-30 1982-08-19 Inc Centocor Essai immunologique pour antigenes multi-determinants
WO1982003330A1 (fr) * 1981-03-30 1982-10-14 Christian Trepo Procede de preparation d'antigenes de l'hepatite virale nanb, et application a la realisation d'un reactif permettant le diagnostic et le pronostic des infections provoquees par les virus des hepatites virales

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8401107A1 *

Also Published As

Publication number Publication date
JPS59501774A (ja) 1984-10-25
WO1984001107A1 (fr) 1984-03-29
EP0119259A1 (fr) 1984-09-26

Similar Documents

Publication Publication Date Title
LV10726A (lv) Hepatita C virusa diagnostikas lidzekli un vakcinas
DE3279434D1 (en) Ultrasonic blood flow sensing apparatus
DE3280128D1 (de) Modifiziertes vaccinia virus und verfahren zu dessen herstellung und verwendung.
ATE51225T1 (de) Verfahren zur herstellung von 2-oxo-1,3dioxolanen.
DE3782262D1 (de) Immunologisch wirksame molkefraktion und rueckgewinnungsverfahren.
TR24082A (tr) Herbisid triazolsulfanomidler bunlarin hazirlanma- sina mahsus usuller ve bunlari ihtiva eden bilesim ler
DE69015261D1 (de) Verfahren zum Nachweis des humanen Papillomvirus.
EP0029063A4 (fr) Procede de detection de l'antigene associe de l'hepatite non-a, non-b.
FR2344629A1 (fr) Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
ES2024040B3 (es) Dispositivo de control no destructivo de tubos mediante ultrasonidos.
FI811936A7 (fi) Järjestely potilaan veren kaasupitoisuuksien määrittämiseksi ja tarkkailemiseksi.
JPS54126596A (en) Method of detecting or fixing virus antigen or red blood* bacteria antigen or antigen
EP0071640A4 (fr) Virus de l'hepatite non a et non b.
ZA825555B (en) Oral vaccine for immunization against enteric disease
DE3578454D1 (de) Klinisches analysesystem und verfahren.
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
DE3380911D1 (de) Aufzeichnungsverfahren eines diagnoseresultats.
FI850051A7 (fi) Virusantigeeni, menetelmä sen talteenottamiseksi ja käyttämiseksi diag noosissa ja terapiassa.
OA06475A (fr) Procédé de récupération d'uranium.
HU906639D0 (en) Diagnostic process for detecting htlv-i peptides and their antibodies causing infection, and vaccine for treating the disease
EP0119259A4 (fr) Virus de l'hepatite non a, non b, procedes d'identification, de purification, de caracterisation, de diagnostic et d'immunisation.
KR890700229A (ko) 혈액친화 진단방법
OA09026A (en) Method for detecting antibodies to human immunodeficiency virus.
DE3486291D1 (de) Verfahren zur Blutabnahme.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19840516

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19880804

17Q First examination report despatched

Effective date: 19890605

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19891017

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SHAFRITZ, DAVID, A.

Inventor name: WANDS, JACK